Favorable kidney outcomes observed for BEL vs PBO in pts with SLE, including fewer kidney flares, greater kidney improvement (SELENA-SLEDAI), less kidney worsening (BILAG), and improved eGFR. Abs 0352 #ACR22 @RheumNow https://t.co/w50uEYVDup https://t.co/JyKZEZG6DZ
Links:
The Effect of Belimumab (BEL) on Kidney Outcomes in SLE: Results of a Large Int…
http://ow.ly/IVcZ50LvA9o
13-11-2022